According to Precigen's latest financial reports and stock price the company's current Operating Margin is -141.00%. At the end of 2021 the company had an Operating Margin of -93.31%.
Year | Operating Margin | Change |
---|---|---|
2021 | -93.31% | -7.3% |
2020 | -100.66% | -56.24% |
2019 | -230.03% | -31.12% |
2018 | -333.95% | 494.72% |
2017 | -56.15% | -44.78% |
2016 | -101.69% | 102.97% |
2015 | -50.10% | -57.96% |
2014 | -119.17% | -30.78% |
2013 | -172.17% | -70.72% |
2012 | -587.96% | -44.75% |
2011 | -1,064.27% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Organovo ONVO | -591.52% | 319.52% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | -129.00% | -8.51% | ๐ฌ๐ง UK |
Novavax NVAX | -149.57% | 6.08% | ๐บ๐ธ USA |
Novocure
NVCR | -37.52% | -73.39% | Jersey |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.